IN VITRO DIAGNOSIS (IVD) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-131102 | Pharmaceuticals and Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
In Vitro Diagnosis (IVD) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET
7.1 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA IN VITRO DIAGNOSIS (IVD) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Roche
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Abbott
16.3 Danaher
16.4 Siemens
16.5 Thermo Fisher Scientific
16.6 Sysmex
16.7 Biomerieux
16.8 Ortho Clinical Diagnostics
16.9 Becton Dickinson
16.10 Bio-Rad Laboratories
16.11 Hologic
16.12 Johnson and Johnson
16.13 Qiagen
16.14 Myriad Genetics
16.15 Wondfo
16.16 KHB
16.17 DAAN Gene
16.18 Leadman Biochemistry
16.19 Mindray
16.20 BioSino
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Typeby Product Type
In Vitro Diagnostic Reagents
In Vitro Diagnostic Instruments
by Diagnostic Method
Immunoassays
Molecular diagnostics involves
Point-of-care testing (POCT)
chemistry Diagnosis
By Application
Physical Examination
Chronic Disease Management
Heavy Disease Surveillance
Companies
Roche
Abbott
Danaher
Siemens
Thermo Fisher Scientific
Sysmex
Biomerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
Johnson and Johnson
Qiagen
Myriad Genetics
Wondfo
KHB
DAAN Gene
Leadman Biochemistry
Mindray
BioSino
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.